{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T20:47:57Z","timestamp":1792356477634,"version":"4.4.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"vor","delay-in-days":1917,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Marrow Donor Program"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.bbmt.2010.01.008","type":"journal-article","created":{"date-parts":[[2010,1,29]],"date-time":"2010-01-29T06:59:50Z","timestamp":1264748390000},"page":"443-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Follicular Lymphoma: An Evidence-Based Review"],"prefix":"10.1016","volume":"16","author":[{"given":"Denise M.","family":"Oliansky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo I.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginna","family":"Laport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Soiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen W.","family":"van Besien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Philip L.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2010.01.008_bib1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1083-8791(01)80003-3","article-title":"The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review","volume":"7","author":"Hahn","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/bbmt.2003.50002","article-title":"The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review","volume":"9","author":"Hahn","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib3","first-page":"11","article-title":"The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review","author":"Hahn","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbmt.2005.10.018","article-title":"The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review","volume":"12","author":"Hahn","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbmt.2006.10.024","article-title":"The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review","volume":"13","author":"Oliansky","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbmt.2007.11.002","article-title":"The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in adults: an evidence-based review","volume":"14","author":"Oliansky","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbmt.2008.12.003","article-title":"The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review","volume":"15","author":"Oliansky","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bbmt.2005.06.005","article-title":"The evolution of the evidence-based review: evaluating the science enhances the art of medicine-statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation","volume":"11","author":"Jones","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib9","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1182\/blood-2007-10-116749","volume":"111","author":"Ladetto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib10","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1200\/JCO.2004.06.016","volume":"22","author":"Lenz","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib11","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood-2006-03-013193","volume":"108","author":"Sebban","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib12","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2004-03-0982","article-title":"Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group","volume":"104","author":"Lenz","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2008-05-160200","article-title":"High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years","volume":"113","author":"Gyan","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib14","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1182\/blood-2004-10-3920","article-title":"High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS","volume":"105","author":"Deconinck","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1182\/blood.V97.2.404","article-title":"High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial","volume":"97","author":"Horning","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib16","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1200\/JCO.2007.15.5358","article-title":"Impact of rituximab and\/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study","volume":"26","author":"Sebban","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib17","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2003.10.023","article-title":"High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP Trial","volume":"21","author":"Schouten","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib18","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1023\/A:1008399623564","article-title":"High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol","volume":"11","author":"Brice","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib19","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1200\/JCO.2006.09.8327","article-title":"Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up","volume":"25","author":"Rohatiner","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib20","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1182\/blood-2003-04-1205","article-title":"Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma","volume":"102","author":"van Besien","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib21","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1200\/JCO.2003.08.054","volume":"21","author":"Bierman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/annonc\/mdg200","article-title":"Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma","volume":"14","author":"Hosing","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bmt.1701556","article-title":"High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin","volume":"23","author":"Stein","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.2008.07067.x","article-title":"Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma","volume":"141","author":"Ingram","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s002770100321","article-title":"Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?","volume":"80","author":"Seyfarth","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib26","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1200\/JCO.2007.14.4204","article-title":"Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei Linfomi Survey","volume":"26","author":"Tarella","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib27","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1200\/JCO.2004.05.035","article-title":"Effects of pretransplantation treatment with Rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma","volume":"22","author":"Hoerr","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib28","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.bmt.1705849","article-title":"Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma","volume":"40","author":"Kang","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib29","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1200\/JCO.1996.14.9.2454","article-title":"Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry","volume":"14","author":"Williams","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib30","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/blood-2003-02-0622","article-title":"High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis","volume":"102","author":"Gopal","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bmt.1703179","article-title":"Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens","volume":"28","author":"Gutierrez-Delgado","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/sj.bmt.1701101","article-title":"High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphoma","volume":"21","author":"Weaver","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbmt.2007.11.004","article-title":"Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning","volume":"14","author":"Hari","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib34","article-title":"Rituximab in combination with CHOP in patients with follicular lymphoma: analysis of treatment outcome of 552 patients treated in a randomized trial of the German Low Grade Lymphoma Study Group (GLSG) after a follow up of 58 months","volume":"112","author":"Buske","year":"2008","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.bbmt.2010.01.008_bib35","first-page":"2189","article-title":"Impact of autologous stem cell transplantation and\/or Rituximab on outcome of patients with relapsed follicular lymphoma\u2014Retrospective analysis of 2 randomized trials of the German Low Grade Lymphoma Study Group (GLSG)","volume":"112","author":"Weigert","year":"2008","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.bbmt.2010.01.008_bib36","first-page":"18012","article-title":"Maintenance immunotherapy after autologous bone marrow transplantation (ABMT) in relapsed follicular (R-FL) and mantle cell (R-MC) lymphomas (NHL). A monoinstitutional experience","volume":"26","author":"Rupolo","year":"2008","journal-title":"ASCO Meet Abstr"},{"key":"10.1016\/j.bbmt.2010.01.008_bib37","first-page":"1902","article-title":"Prolonged clinical and molecular remissions following high-dose therapy\/autologous stem cell transplantation (HDT\/ASCT) and Rituximab and Interferon-alpha maintenance for relapsed high-risk follicular lymphoma","volume":"110","author":"Cheung","year":"2007","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.bbmt.2010.01.008_bib38","first-page":"22","article-title":"90Yttrium Ibritumomab Tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory follicular lymphoma. GELA Phase II study","volume":"110","author":"Gisselbrecht","year":"2007","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.bbmt.2010.01.008_bib39","first-page":"458","article-title":"Reduced intensity allogeneic stem cell transplantation for follicular lymphoma results in an improved progression free survival when compared to autologous stem cell transplantation. An analysis from the Lymphoma Working Party of the EBMT","volume":"112","author":"Robinson","year":"2008","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.bbmt.2010.01.008_bib40","first-page":"7041","article-title":"Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with follicular non-hodgkins lymphoma (FL) beyond first complete response or first partial response","volume":"26","author":"Laport","year":"2008","journal-title":"ASCO Meet Abstr"},{"key":"10.1016\/j.bbmt.2010.01.008_bib41","first-page":"7036","volume":"26","author":"Sureda","year":"2008","journal-title":"ASCO Meet Abstr"},{"key":"10.1016\/j.bbmt.2010.01.008_bib42","first-page":"3303","volume":"112","author":"Corradini","year":"2008","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.bbmt.2010.01.008_bib43","first-page":"485","article-title":"Nonmyeloablative allogeneic transplantation (NMT) for relapsed follicular lymphoma (FL): continuous complete remission with longer follow-up","volume":"110","author":"Khouri","year":"2007","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.bbmt.2010.01.008_bib44","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.bbmt.2007.05.012","article-title":"Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission","volume":"13","author":"Brown","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib45","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1080\/10428190701583983","article-title":"The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation","volume":"48","author":"Keeney","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2010.01.008_bib46","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.bmt.1702336","article-title":"Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT)","volume":"25","author":"Voso","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib47","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/sj.leu.2404346","article-title":"Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial","volume":"20","author":"Ladetto","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.01.008_bib48","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood.V88.7.2780.bloodjournal8872780","article-title":"High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission","volume":"88","author":"Freedman","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib49","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.bmt.1703829","article-title":"PCR detection of residual Bcl-2\/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma","volume":"31","author":"Mahe","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib50","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.leu.2401737","article-title":"Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft","volume":"14","author":"Tarella","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.01.008_bib51","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2004.10.054","article-title":"Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes","volume":"22","author":"Corradini","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1634\/stemcells.2005-0613","article-title":"Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells","volume":"25","author":"Witzens-Harig","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbmt.2010.01.008_bib53","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.bmt.1702631","article-title":"Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study","volume":"26","author":"Colombat","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib54","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","article-title":"Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma","volume":"94","author":"Freedman","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1200\/JCO.1997.15.2.445","article-title":"High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma","volume":"15","author":"Bierman","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib56","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2000.18.3.527","article-title":"High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up","volume":"18","author":"Apostolidis","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib57","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/bbmt.2001.v7.pm11400952","article-title":"High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience","volume":"7","author":"Cao","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib58","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2005.12.040","article-title":"Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?","volume":"12","author":"Krishnan","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib59","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/sj.leu.2404850","article-title":"Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study","volume":"21","author":"Montoto","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.01.008_bib60","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbmt.2007.06.016","article-title":"Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index","volume":"14","author":"Vose","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib61","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/sj.bmt.1705864","article-title":"The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma","volume":"40","author":"Pham","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib62","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/cncr.22383","article-title":"High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma","volume":"109","author":"Vignot","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2010.01.008_bib63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbmt.2004.11.017","article-title":"Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma","volume":"11","author":"Laudi","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib64","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/annonc\/mdn044","article-title":"Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma","volume":"19","author":"Arcaini","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbmt.2004.09.003","article-title":"High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed\/refractory lymphoma: an effective regimen with low morbidity and mortality","volume":"11","author":"Wadhwa","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib66","first-page":"350","article-title":"Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience","volume":"84","author":"Lopez","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2010.01.008_bib67","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00277-006-0149-6","article-title":"Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma","volume":"85","author":"Leger","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib68","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/blood.V86.8.3257.3257","article-title":"Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma","volume":"86","author":"Bastion","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib69","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.bmt.1705178","article-title":"Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma","volume":"36","author":"Andreadis","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib70","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1365-2141.2001.02705.x","article-title":"Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma","volume":"113","author":"Chen","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib71","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1053\/bbmt.1999.v5.pm10465106","article-title":"Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies","volume":"5","author":"Friedberg","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib72","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0609.2008.01146.x","article-title":"High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma","volume":"81","author":"Hamadani","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib73","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bmt.1703891","article-title":"An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation","volume":"31","author":"Peniket","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib74","first-page":"1832","article-title":"Allogeneic bone marrow transplantation for low-grade lymphoma","volume":"92","author":"van Besien","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib75","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbmt.2008.04.007","article-title":"Favorable overall survival with fully myeloablative allogeneic stem cell transplantation for follicular lymphoma","volume":"14","author":"Kuruvilla","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib76","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2141.2004.05194.x","article-title":"Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation","volume":"127","author":"Toze","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib77","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.bmt.1703790","article-title":"Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin's lymphoma","volume":"31","author":"Kiss","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib78","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3324\/haematol.10924","article-title":"Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)","volume":"92","author":"Vigouroux","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2010.01.008_bib79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1200\/JCO.2007.11.5477","article-title":"Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma","volume":"26","author":"Rezvani","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.01.008_bib80","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1182\/blood-2001-11-0107","article-title":"Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation","volume":"100","author":"Robinson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib81","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1182\/blood-2008-01-136242","article-title":"Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab","volume":"111","author":"Khouri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib82","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.bmt.1705027","article-title":"Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: a retrospective survey of 112 adult patients in Japan","volume":"36","author":"Kusumi","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.01.008_bib83","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2004-03-1105","article-title":"Outcomes after\u00a0alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma","volume":"104","author":"Morris","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib84","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/blood-2003-05-1406","article-title":"BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients","volume":"103","author":"Faulkner","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.01.008_bib85","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.bbmt.2008.09.008","article-title":"Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic stem cell transplantation (HCT): a report from the Center for International Blood & Marrow Transplant Research (CIBMTR)","volume":"14","author":"Lazarus","year":"2008","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:35:20Z","timestamp":1761057320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879110000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1083879110000248"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.01.008","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Follicular Lymphoma: An Evidence-Based Review","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}